𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Current Status of Tumor M2 Pyruvate Kinase (Tumor M2-PK) as a Biomarker of Gastrointestinal Malignancy

✍ Scribed by Harsha R. Hathurusinghe; Kolitha S. Goonetilleke; Ajith K. Siriwardena

Book ID
111772101
Publisher
Springer
Year
2007
Tongue
English
Weight
208 KB
Volume
14
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prospective multicenter evaluation of fe
Prospective multicenter evaluation of fecal tumor pyruvate kinase type M2 (M2-PK) as a screening biomarker for colorectal neoplasia
✍ Yogesh M. Shastri; Marc Naumann; Gerhard M. Oremek; Ernst Hanisch; Wolfgang RΓΆsc πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 136 KB

## Abstract Proliferating cells, particularly the tumor cells, express a dimeric isoenzyme of pyruvate kinase, termed M2‐PK. It's a direct target of several oncoproteins; the determination of fecal tumor pyruvate kinase type M2 (M2‐PK) might be another promising tool for colorectal cancer (CRC) scr

Tumor type M2 pyruvate kinase (TuM2-PK)
Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma
✍ Selma Ugurel; Nellie Bell; Antje Sucker; Anette Zimpfer; Werner Rittgen; Dirk Sc πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 201 KB

## Abstract Proliferating cells express the pyruvate kinase isoenzyme type M2 (M2‐PK). This enzyme exists as an active tetramer and an inactive dimer. The dimeric form is predominantly found in tumor cells and is therefore termed Tumor M2‐PK (TuM2‐PK). TuM2‐PK molecules are released into the periph

Fecal dimeric M2-pyruvate kinase (tumor
Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders
✍ Jinny Jeffery; Stephen J. Lewis; Ruth M. Ayling πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 109 KB

Background: Fecal inflammatory markers have been shown to be useful as noninvasive screening tools to differentiate patients with functional from organic bowel pathology. Of these markers calprotectin has been the most intensively studied. More recently, the dimeric isoform of M2-pyruvate kinase (tu